SecurityUVE / Universal Insurance Holdings, Inc. (91359V107)
IndustryFire, Marine, and Casualty Insurance
Common Shares Outstanding34,872,073 shares (as of 2018-06-30)
Total Insiders11
Total Directors9
Total Officers4

Stock Insider Trading (from SEC Form 4)

UVE / Universal Insurance Holdings, Inc. Insider Trades

Universal Insurance Holdings, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

UVE / Universal Insurance Holdings, Inc. insiders include DOWNES SEAN P, PALMIERI RALPH J., Callahan Scott P., and Donaghy Stephen, Springer Jon, WILENTZ JOEL, SCHINDLER OZZIE A, PETERSON RICHARD D, Lewis Darryl L., Wilcox Frank PIETRANGELO MICHAEL, .

Insider Roster

Insider Dir Off 10% Shares Owned
Springer Jon President and CRO, Director
X X 455,725
DOWNES SEAN P CEO, Director
X X 1,399,141
Lewis Darryl L. Director
X 20,120
PIETRANGELO MICHAEL Director
X 70,763
Donaghy Stephen COO
X 448,902
PALMIERI RALPH J. Director
X 7,898
Wilcox Frank CFO, Principal Acct. Officer
X 132,324
SCHINDLER OZZIE A Director
X 21,424
PETERSON RICHARD D Director
X 1,065
Callahan Scott P. Director
X 8,536
WILENTZ JOEL Director
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-08-10 4 Springer Jon S X D 45.1543 -7,000 455,725 20,577,943
2018-08-01 4 Lewis Darryl L. F D 44.2 -21,205 20,120
2018-08-01 4 Lewis Darryl L. M D 19.85 20,000 41,325
2018-08-01 4 Lewis Darryl L. M D 11.92 20,000 21,325
2018-08-02 4 Springer Jon S D 45.2985 -20,000 462,725 20,960,748
2018-08-02 4 DOWNES SEAN P S D 45.3601 -20,000 1,399,141 63,465,176
2018-07-31 4 Springer Jon S D 45.4459 -7,000 482,725 21,937,872
2018-07-31 4 PIETRANGELO MICHAEL S D 44.5304 -10,000 70,763 3,151,105
2018-07-31 4 DOWNES SEAN P S D 45.2329 -1,000 1,419,141 64,191,863
2018-07-31 4 DOWNES SEAN P S D 44.7266 -19,000 1,420,141 63,518,078
2018-07-30 4 Donaghy Stephen S D 43.1986 -9,191 448,902 19,391,938
2018-07-27 4 Donaghy Stephen S D 42.3314 -10,514 458,093 19,391,718
2018-07-24 4 DOWNES SEAN P S D 37.8048 -20,000 1,439,141 54,406,438
2018-07-10 4 Springer Jon S X D 35.5171 -7,000 489,725 17,393,612
2018-06-25 4 DOWNES SEAN P S D 34.9112 -20,000 1,459,141 50,940,363
2018-05-30 4 PALMIERI RALPH J. S D 36.4127 -7,800 7,898 287,588
2018-05-24 4 DOWNES SEAN P S D 35.7717 -20,000 1,479,141 52,911,388
2018-05-17 4 Springer Jon S D 35.344 -18,926 496,725 17,556,248
2018-05-03 4 Wilcox Frank S D 32.3606 -14,000 132,324 4,282,084
2018-05-02 4 PALMIERI RALPH J. F D 32.9 -18,319 15,698
2018-05-02 4 PALMIERI RALPH J. M D 20.09 30,000 34,017
2018-05-01 4 DOWNES SEAN P S D 32.776 -50,000 1,499,141 49,135,845
2018-05-01 4 SCHINDLER OZZIE A S D 33 -34,076 21,424 706,992
2018-04-30 4 SCHINDLER OZZIE A S D 33.01 -500 55,500 1,832,055
2018-04-09 4 PETERSON RICHARD D By The RDP Revocable Trust dated August 11, 2011 F I 30.85 -515 1,065
2018-04-09 4 PETERSON RICHARD D By The RDP Revocable Trust dated August 11, 2011 M I 19.85 800 1,580
2018-04-04 4 Springer Jon F D 32.25 -147,119 515,651
2018-04-04 4 Springer Jon M D 19.52 22,333 662,770
2018-04-04 4 Springer Jon M D 19.52 165,016 640,437
2018-03-20 4 DOWNES SEAN P F D 32.7 -475,174 1,549,141
2018-03-20 4 DOWNES SEAN P M D 19.52 300,000 2,024,315
2018-03-20 4 DOWNES SEAN P M D 19.52 133,334 1,724,315
2018-03-20 4 DOWNES SEAN P M D 24.18 175,000 1,590,981
2018-02-23 4 PIETRANGELO MICHAEL S D 30.244 -16,955 80,763 2,442,596
2018-02-23 4 Callahan Scott P. S D 30.526 -2,600 8,536 260,570
2018-02-22 4 Callahan Scott P. F D 30.85 -3,864 11,136
2018-02-22 4 Callahan Scott P. M D 11.92 10,000 15,000
2018-02-22 4 Wilcox Frank A D 50,000 146,324
2018-02-08 4 PIETRANGELO MICHAEL F D 29.1 -6,974 97,718
2018-02-08 4 PIETRANGELO MICHAEL M D 4.51 45,000 104,692
2018-01-22 4 DOWNES SEAN P F D 30 -26,953 1,415,981
2018-01-22 4 DOWNES SEAN P M D 73,529 1,442,934
2018-01-22 4 Springer Jon F D 30 -7,500 475,421
2018-01-22 4 Springer Jon M D 24,510 482,921
2018-01-02 4 Springer Jon F D 27.3 -2,643 458,411
2018-01-02 4 Springer Jon M D 7,190 461,054
2018-01-02 4 DOWNES SEAN P F D 27.3 -6,126 1,369,405
2018-01-02 4 DOWNES SEAN P M D 21,570 1,375,531
2017-11-28 4 PIETRANGELO MICHAEL S D 26.2692 -9,969 59,692 1,568,061
2017-11-20 4 Donaghy Stephen F D 26.35 -79,462 468,607
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Universal Insurance: The Beast Is Unleashed

2018-07-30 seekingalpha
Growth was off the charts: Revenue increased over 13% and EPS growth nearly reached 60%. Book value compounded at ~20%. Return on Equity nearly reached 40%.

Universal Insurance Holdings: An Emerging Dividend Growth Machine

2018-07-09 seekingalpha
UVE enjoys a lengthy growth runway and displayed the strength of its reinsurance program in the aftermath of hurricane Irma.

4 Notable Dividend Increases From the Past Week

2018-06-04 investorplace
The S&P 500 Index edged higher last week after investors reacted positively to another strong report on the U.S. labor market. With corporate profits heading higher, several companies rewarded shareholders with news of fresh dividend raises. (12-0)

Universal Expects Mid-Year Reinsurance Renewal Pricing To Be Lower

2018-05-01 seekingalpha
The mid-year reinsurance renewal at June 1st is expected to yield pricing that is lower than last year for Florida-headquartered primary insurance company Universal Insurance Holdings (NYSEMKT:UVE), which expects to be able to keep its retention static, while buying more coverage at comparable or lower rates. (9-0)

BRIEF-Universal Insurance CEO Sean Downes's FY 2017 Total Compensation Was $19.3 Million

2018-04-27 reuters
* UNIVERSAL INSURANCE HOLDINGS INC - CEO SEAN DOWNES'S FY 2017 TOTAL COMPENSATION WAS $19.3 MILLION VERSUS $16.3 MILLION IN FY 2016 - SEC FILING Source text for Eikon: (bit.ly/2KkM5RB) Further company coverage: (9-1)